Increased cyclic AMP response to forskolin in Epstein-Barr virus-transformed human B-lymphocytes derived from schizophrenics

Psychopharmacology

Volumn 130, Issue 3, 1997, Pages 235-241

  Natsukari, Naoki ^a   Kulaga, Henrietta ^a   Baker, Ivory ^a   Wyatt, Richard Jed ^a   Masserano, Joseph M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

adenylyl cyclase; B lymphocyte; cholera toxin; cyclic AMP; forskolin; isoproterenol; phorbol ester; prostaglandin E1; schizophrenia

Indexed keywords

CHOLERA TOXIN; CYCLIC AMP; FORSKOLIN; ISOPRENALINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL DIDECANOATE; PHORBOL ESTER; PROSTAGLANDIN E1; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; STAUROSPORINE;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; ENZYME ACTIVATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFORMATION; MALE; PHOSPHORYLATION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ALPROSTADIL; B-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; CHOLERA TOXIN; CYCLIC AMP; FEMALE; FORSKOLIN; HERPESVIRUS 4, HUMAN; HUMANS; ISOPROTERENOL; LYMPHOCYTE ACTIVATION; MALE; SCHIZOPHRENIA; TETRADECANOYLPHORBOL ACETATE;

EID: 0030996306     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050234     Document Type: Article

References (35)

1. Bell JD, Brunton LL (1987) Multiple effects of phorbol esters on hormone-sensitive adenylate cyclase activity in S49 lymphoma cells. Am J Physiol 252:E783-E789
2. 3H-Spiperone binding sites in lymphocytes as possible vulnerability marker in schizophrenia. J Psychiatr Res 21:521-529
3. Choi EJ, Wong ST, Dittman AH, Storm DR (1993) Phorbol ester stimulation of the type I and type III adenylyl cyclases in whole cells. Biochemistry 32:1891-1894
4. Cooper DMF, Mons N, Karpen JW (1995) Adenylyl cyclases and the interaction between calcium and cAMP signaling. Nature 374:421-424
5. Ebstein RP, Lerer B, Shapira B, Shemesh Z, Moscovich DG, Kindler S (1988) Cyclic AMP second-messenger signal amplification in depression. Br J Psychiatry 152:665-669
6. Ebstein RP, Bennett ER, Hadjez J, Silver H, Yedgar S, Lerer B (1990) Cyclic AMP second messenger signal generation in EBV-transformed lymphoblastoid cells from schizophrenic patients. J Psychiatry Res 24:121-127
7. Erickson RP, Pairitz GL, Karolyi JM, Kapur JJ, Odenheimer DJ, Schultz JS, Sing CF (1985) HLA-B18 is associated with decreased levels of isoproterenol-stimulated cAMP in lymphocytes. Am J Hum Genet 37:124-132
8. Hellevuo K, Yoshimura M, Mons N, Hoffman PL, Cooper DM, Tabakoff B (1995) The characterization of a novel human adenylyl cyclase which is present in brain and other tissues. J Biol Chem 270:11581-11589
9. Hudson CJ, Trevor Y, Li PP, Warsh JJ (1993) CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 13:278-293
10. Ishikawa Y, Katsushika S, Chen L, Halnon NJ, Kawabe J, Homcy CJ (1992) Isolation and characterization of a novel cardiac adenylyl cyclase cDNA. J Biol Chem 267:13553-13557
11. 1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation. Psychopharmacol Bull 26:381-384
12. Kassis S, Zaremba T, Patel J, Fishman PH (1985) Phorbol esters and β-adrenergic agonists mediate desensitization of adenylate cyclase in rat glioma C6 cells by distinct mechanisms. J Biol Chem 260:8911-8917
13. Kawabe J, Iwami G, Ebina T, Ohno S, Katada T, Ueda Y, Homcy CJ, Ishikawa Y (1994) Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J Biol Chem 269:16554-16558
14. Kay G, Sargeant M, McGuffin P, Whatley S, Marchbanks R, Baldwin D, Montgomery S, Elliott JM (1993) The lymphoblast beta-adrenergic receptor in bipolar depressed patients: characterization and down-regulation. J Affect Disord 27:163-172
15. Kerwin RW, Beats BC (1990) Increased forskolin binding in the left parahippocampal gyrus and CA1 region in post mortem schizophrenic brain determined by quantitative autoradiography. Neurosci Lett 118:164-168
16. Laurenza A, Satkowski EM, Seamon KB (1989) Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol Sci 10:442-447
17. Maddock RJ, Carter CS, Magliozzi JR, Gietzen DW (1993) Evidence that decreased function of lymphocyte beta adrenoreceptors reflects regulatory and adaptive processes in panic disorder with agoraphobia. Am J Psychiatry 150:1219-1225
18. 2+-inhibitable adenylyl cyclase in dopaminergically innervated rat brain regions. Brain Res Mol Brain Res 22:236-244
19. 1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics. Science 221:1304-1307
20. 2+-insensitive adenylyl cyclases in the rat brain. Synapse 14:51-59
21. Moyers JS, Bouton AH, Parsons SJ (1993) The sites of phosphorylation by protein kinase C and an intact SH2 domain are required for the enhanced response to β-adrenergic agonists in cells overexpressing c-src. Mol Cell Biol 13:2391-2400
22. 1, cholera toxin, forskolin, and phorbol 12-myristate-13 acetate. Prog Neuropsychopharmacol Biol Psychiatry 20:99-108
23. 3H]cAMP binding sites and decrease in Gi alpha and Go alpha immunoreactivities in left temporal cortices from patients with schizophrenia. Brain Res 615:41-49
24. Okada F, Crow TJ, Roberts GW (1991) G proteins (Gi, Go) in the medial temporal lobe in schizophrenia: preliminary report of a neurochemical correlate of structural change. J Neural Transm [Gen Sect] 84:147-153
25. Patke CL, Shearer WT (1990) Enhancement of cyclic AMP metabolism in a B cell line by protein kinase C. Cell Immunol 130:22-31
26. Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346-356
27. Schinelli S, Paolillo M, Corona GL (1994) Modulation of dopamine-induced cAMP production in rat striatal cultures by the calcium ionophore A23187 and by phorbol-12-myristate-13-acetate. Brain Res Mol Brain Res 21:162-166
28. 2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology 1:5-15
29. 2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc Natl Acad Sci USA 86:10156-10160
30. Spitzer R, Williams J, Gibbon M (1986) Structured clinical interview for DSM-III-R(SCID). New York Psychiatric Institute, New York
31. Watson PA, Krupinski J, Kempinski AM, Frankenfield CD (1994) Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells. J Biol Chem 269:28893-28898
32. Yoshimasa T, Sibley DR, Bouvier M, Lefkowitz RJ, Caron G (1987) Cross-talk between cellular signalling pathways suggested by phorbol ester induced adenylate cyclase phosphorylation. Nature 327:67-70
33. Yoshimura M, Cooper DM (1993) Type-specific stimulation of adenylyl cyclase by protein kinase C. J Biol Chem 268: 4604-4607
34. Young LT, Li PP, Kish SJ, Siu KP, Kamble A, Hornykiewicz O, Warsh JJ (1993) Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem 61:890-898
35. Zhou XM, Curran P, Baumgold J, Fishman PH (1994) Modulation of adenylyl cyclase by protein kinase C in human neurotumor SK-N-MC cells: evidence that the alpha isozyme mediates both potentiation and desensitization. J Neurochem 63:1361-1137